ADVERTISEMENT

After substance withdrawal, underlying psychiatric symptoms emerge

Current Psychiatry. 2014 December;13(12):26-32
Author and Disclosure Information

Prompt identification and treatment can ease suffering

Studies show that treating ADHD, even with stimulants, neither helps nor hurts out­comes in substance use. Lisdexamfetamine is difficult to abuse and is an inactive prodrug (a bond of lysine and dextroamphetamine) that requires enzymatic cleavage and activa­tion by red blood cells; these characteristics creates a long-acting medication that has a lower abuse liability than other drugs for ADHD. However, abuse can occur and the drug must be used cautiously. Earley’s medi­cation guide referenced below recommends that lisdexamfetamine and other stimulants should be avoided if possible in patients in recovery. However, it adds that special­ists in treating ADHD in substance-abusing patients should weigh the potential benefits of stimulant use against the risk of relapse.17 Many patients enter treatment with a diag­nosis of bipolar disorder that might, in fact, be comorbid with ADHD.


Chronic pain

Many substance abuse patients began taking opioids for acute, then chronic, pain before their use escalated to addiction. These are challenging patients; often, they are referred for treatment without true addiction.

Keep in mind that dependence is not addiction. Pseudo-addiction is a condition in which pain is undertreated and the patient takes more medication to obtain relief, calls for early refills, and displays drug-seeking behavior but is not using drugs to achieve euphoria. A thorough history and physical and referrals to specialists such as orthopedic surgeons and pain specialists are necessary. Explaining opioid-induced hyperalgesia is important to help the patient understand that (1) pain can be made worse by increas­ing the dosage of an opioid because of supersensitivity and (2) many patients who are weaned off these drugs will experience a decrease or complete relief of pain.21

Gabapentin, duloxetine, or amitriptyline can be beneficial for chronic pain, as well as mindfulness techniques, physical therapy, and complementary and alternative medi­cine. Pregabalin can produce euphoria and often should be avoided.


A medication guide for recovery

Paul Earley, MD, former medical director at Talbott Recovery in Atlanta, Georgia, pub­lishes an online guide that classifies medica­tions into categories:
   • A: safe
   • B: use only under the supervision of an addiction medicine specialist or doctor
   • C: completely avoid if the patient is in recovery.17

The Talbott guide lists all stimulants in category C, (except for atomoxetine, which is category A). Hydroxyzine is listed under category B. Many programs for impaired professionals and state medical boards use the Guide, and will question the prescribing of any medication from categories B and C.17

Related Resources
• Spiegel DR, Kumari N, Petri JD. Safer use of benzodiaz­epines for alcohol detoxification. Current Psychiatry. 2012;11(10):10-15.
• Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012;37(1):11-24.

Drug Brand Names
Amitriptyline • Elavil                                     Hydrocodone • Vicodin
Atenolol • Tenormin                                      Hydroxyzine • Vistaril, Atarax
Atomoxetine • Strattera                                Lisdexamfetamine • Vyvanse
Buprenorphine/ naloxone • Suboxone             Metoprolol • Lopressor, Toprol
Buspirone • BuSpar                                       Paroxetine • Paxil
Carbidopa-levodopa • Sinemet                       Pramipexole • Mirapex
Clonazepam • Klonopin                                  Prazosin • Minipress
Diazepam • Valium                                        Pregabalin • Lyrica
Doxepin • Silenor, Adapin, Sinequan               Propranolol • Inderal
Duloxetine • Cymbalta                                   Quetiapine • Seroquel
Escitalopram • Lexapro                                  Ropinirole • Requip
Gabapentin • Neurontin, Horizant                   Sertraline • Zoloft
                                                                   Trazodone • Desyrel

Disclosure
The author reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.